Canada markets open in 6 hours 44 minutes

Amneal Pharmaceuticals, Inc. (2DT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
5.950.00 (0.00%)
As of 03:29PM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.87B
Enterprise Value 4.38B
Trailing P/E 93.81
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.55
Price/Book (mrq)5.21
Enterprise Value/Revenue 1.89
Enterprise Value/EBITDA 13.54

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 3140.31%
S&P500 52-Week Change 324.96%
52 Week High 36.55
52 Week Low 32.32
50-Day Moving Average 35.94
200-Day Moving Average 34.93

Share Statistics

Avg Vol (3 month) 316
Avg Vol (10 day) 3N/A
Shares Outstanding 5308.65M
Implied Shares Outstanding 6314.18M
Float 8132.67M
% Held by Insiders 157.00%
% Held by Institutions 131.71%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -6.76%
Operating Margin (ttm)12.92%

Management Effectiveness

Return on Assets (ttm)5.45%
Return on Equity (ttm)-165.27%

Income Statement

Revenue (ttm)2.5B
Revenue Per Share (ttm)11.61
Quarterly Revenue Growth (yoy)18.20%
Gross Profit (ttm)N/A
EBITDA 535.36M
Net Income Avi to Common (ttm)-168.69M
Diluted EPS (ttm)-0.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.45M
Total Cash Per Share (mrq)0.16
Total Debt (mrq)2.75B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.65
Book Value Per Share (mrq)-0.21

Cash Flow Statement

Operating Cash Flow (ttm)201.46M
Levered Free Cash Flow (ttm)107.94M